Brief: Ryvu Therapeutics Q2 Net Loss At 33.7 Million Zlotys
18/09/2025 16:16
Sept 18 (Reuters) - Ryvu Therapeutics SA RVU.WA: Q2 NET LOSS AT 33.7 MILLION ZLOTYS Q2 OPERATING REVENUE 21.4 MILLION ZLOTYS Q2 OPERATING LOSS 27.7 MILLION ZLOTYS Source text: ID:nEMyr07Sa Further company coverage: RVU.WA (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Signs Grant Agreement For Panacea-Novo Project With The National Center For Research And Development
Brief: Ryvu Therapeutics Q2 Net Loss 13.1 Million Zlotys
Brief: Ryvu Therapeutics "Dualis" Project Recommended For 22.2 Mln Zloty Subsidy
Brief: Ryvu Therapeutics Launches Early Clinical Development Services Business For Biotech And Pharma In Europe
Brief: Ryvu Therapeutics Says Panacea-Novo Project Recommended For Funding Of 106.7 Mln Zlotys